ALENDRONATE PRODUCES GREATER EFFECTS THAN RALOXIFENE ON BONE DENSITY AND BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH LOW BONE DENSITY: RESULTS OF EFFECT (EFFICACY OF FOSAMAX VERSUS EVISTA COMPARISON TRIAL) INTERNATIONAL

SAMBROOK, P.N., GEUSENS, P., & RIBOT, C.. (2004). ALENDRONATE PRODUCES GREATER EFFECTS THAN RALOXIFENE ON BONE DENSITY AND BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH LOW BONE DENSITY: RESULTS OF EFFECT (EFFICACY OF FOSAMAX VERSUS EVISTA COMPARISON TRIAL) INTERNATIONAL. JOURNAL OF INTERNAL MEDICINE, 255(-), 503-511. SID. https://sid.ir/paper/550346/en

SAMBROOK P.N., GEUSENS P., RIBOT C.. ALENDRONATE PRODUCES GREATER EFFECTS THAN RALOXIFENE ON BONE DENSITY AND BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH LOW BONE DENSITY: RESULTS OF EFFECT (EFFICACY OF FOSAMAX VERSUS EVISTA COMPARISON TRIAL) INTERNATIONAL. JOURNAL OF INTERNAL MEDICINE[Internet]. 2004;255(-):503-511. Available from: https://sid.ir/paper/550346/en

P.N. SAMBROOK, P. GEUSENS, and C. RIBOT, “ALENDRONATE PRODUCES GREATER EFFECTS THAN RALOXIFENE ON BONE DENSITY AND BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH LOW BONE DENSITY: RESULTS OF EFFECT (EFFICACY OF FOSAMAX VERSUS EVISTA COMPARISON TRIAL) INTERNATIONAL,” JOURNAL OF INTERNAL MEDICINE, vol. 255, no. -, pp. 503–511, 2004, [Online]. Available: https://sid.ir/paper/550346/en